Genomic Valley Biotech Ltd
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve unaudited financial ....
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 06 Aug 2026, 12:56 PM IST · BSE ID: aed23992-333a-48e9-a0b3-4d253bffafab
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on August 14, 2026, to approve financial results for the April-June 2026 quarter.
🤖 AI Summary
- Genomic Valley Biotech Ltd to hold Board Meeting on Friday, August 14, 2026.
- Board will consider and approve unaudited standalone financial results for quarter ended June 30, 2026.
- Meeting to take place at the corporate office of Genomic Valley Biotech Ltd.
- Trading window closed from July 01, 2026, until 48 hours post August 14, 2026, results disclosure.
👥 What This Means For Shareholders
✅
Action Required
Shareholders do not need to take any immediate action based on this intimation of a future board meeting.
👤
Who Is Affected
Shareholders will be affected by the financial results once they are approved and disclosed on or after August 14, 2026. Designated persons cannot trade company securities during the closed trading window.
🔍
Management Signal
Management is adhering to regulatory requirements by intimating the board meeting for financial results approval and enforcing a trading window closure.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Board Meeting outcome on August 14, 2026 — check for unaudited financial results.
Unaudited financial results for Q1 FY27 — assess key financial metrics.
Disclosure of actual financial figures after board approval.
LOW RISK
The filing is a routine announcement of a board meeting for results approval; no immediate risks identified.
💡 Investor Takeaway
Genomic Valley Biotech Ltd has intimated a Board Meeting on August 14, 2026, to approve unaudited standalone financial results for the quarter ended June 30, 2026. The trading window is currently closed for designated persons.
❓ Frequently Asked Questions
When is Genomic Valley Biotech Ltd's Board Meeting scheduled?
The Board of Directors meeting for Genomic Valley Biotech Ltd is scheduled for Friday, August 14, 2026.
What is the primary agenda for the Genomic Valley Biotech Ltd Board Meeting on August 14, 2026?
The primary agenda is to consider and approve the unaudited standalone financial results of the Company for the quarter ended June 30, 2026.
When does the trading window for Genomic Valley Biotech Ltd securities close?
The trading window for dealing in Genomic Valley Biotech Ltd securities closed from July 01, 2026, and will remain closed until the end of 48 hours after the results are made public on August 14, 2026.
Who is affected by the trading window closure at Genomic Valley Biotech Ltd?
The trading window closure affects Directors, KMPs, Promoters & Promoters Group, and Designated Persons etc. covered under the company's code for prevention of Insider trading.
Questions based on this BSE filing only. For information purposes.